BOLT vs RUN · rev $7.7M vs P/E 6.0, rev $2.04B
Bolt Biotherapeutics (BOLT) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
BOLT currently screens at market cap $11.3M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the BOLT and RUN stock pages for the full models.
Not investment advice.